"Innovative active agents for previously hard-to-treat diseases"

Exit 2018
Back to portfolio

MIG Capital AG

  • Ismaninger Straße 102
  • D-81675 Munich
  • Germany
Linkedin-in Twitter
Media
About Us
Portfolio
We love to support:
Non-profit Engagement
  • Back To Top